Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Cash and cash equivalents	$ 120,448	$ 64,054
Restricted cash, current	4,745	8,413
Notes receivable	262,967	254,895
Other payables	21,969	6,908
Other current liabilities	27,396	21,053
Unamortized debt issuance costs	$ 1,128	$ 1,268
Common stock par value (in usd per share)	$ 0.00001	$ 0.00001
Common stock authorized (in shares)	750,000,000	750,000,000
Common stock issued (in shares)	34,940,000	35,130,000
Common stock outstanding (in shares)	33,594,000	33,798,000
Treasury stock at cost (in shares)	1,346,000	1,332,000
Variable Interest Entity, Primary Beneficiary
Cash and cash equivalents	$ 39,979	$ 25,921
Restricted cash, current	4,701	8,245
Notes receivable	247,006	237,062
Other payables	7	1,476
Other current liabilities	$ 1,075	$ 0